Report: Biotech Uncertainty, Instability Bogged Down 2025
Massachusetts-headquartered biopharma companies secured $6.85 billion in venture capital funding last year – the smallest haul since 2019.
Healey Urges Lawmakers to Put ‘Stake in the ground’ with $400M Biotech Investment
While $400 million won’t be enough to fill gaps left by federal cuts to higher ed and biotech, Gov. Maura Healey and business leaders argue it will keep Massachusetts from falling behind in the sectors it touts the most.
Report Predicts Biotech Shrinkage as Federal Changes Take Hold
Job and labor force surveys are starting to pick up on the early impacts of President Donald Trump’s trade and tariff policies and other federal government shifts to Massachusetts, economists at MassBenchmarks said.
MassBio Maps Rescue Plan for Life Science Startups
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
